The tumour microenvironment as an integrated framework to understand cancer biology

Autores de INCLIVA
Participantes ajenos a INCLIVA
- de la Cruz-Merino, L
- Alvaro, T
Grupos y Plataformas de I+D+i
Abstract
Cancer cells all share the feature of being immersed in a complex environment with altered element communication, physicochemical information, and tissue functions. The so-called tumour microenvironment (TME) is becoming recognised as a key factor in the genesis, progression and treatment of cancer lesions. Beyond genetic mutations, the existence of a malignant microenvironment forms the basis for a new perspective in cancer biology where connections at the system level are fundamental. From this standpoint, different aspects of tumour lesions such as morphology, aggressiveness, prognosis and treatment response can be considered under an integrated vision, giving rise to a new field of study and clinical management. Nowadays, somatic mutation theory is complemented with study of TME components such as the extracellular matrix, immune compartment, stromal cells, metabolism and biophysical forces. In this review we examine recent studies in this area and complement them with our own research data to propose a classification of stromal changes. Exploring these avenues and gaining insight into malignant phenotype remodelling, could reveal better ways to characterize this disease and its potential treatment.
© 2019 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/)
Datos de la publicación
- ISSN/ISSNe:
- 0304-3835, 1872-7980
- Tipo:
- Review
- Páginas:
- 112-122
- PubMed:
- 31325528
CANCER LETTERS ELSEVIER IRELAND LTD
Citas Recibidas en Web of Science: 74
Documentos
Filiaciones
Keywords
- Biophysics; Bioelectric; Metabolism; Cancer treatment; Extracellular matrix; Stromal classification
Proyectos y Estudios Clínicos
INCORPORACIÓN DE NUEVAS ÁREAS TEMÁTICAS Y NUEVOS GRUPOS AL CONSORCIO CIBER
Investigador Principal: ROSA NOGUERA SALVA
CB16/12/00484 . INSTITUTO SALUD CARLOS III
Identificación y validación de nuevas terapias, modelos preclínicos y marcadores de respuesta terapéutica en neuroblastoma. (PI17/01558).
Investigador Principal: ROSA NOGUERA SALVA
PI17/01558 . INSTITUTO SALUD CARLOS III . 2018
Cita
Burgos R,Lucantoni F,Gamero E,de la Cruz L,Alvaro T,Noguera R. The tumour microenvironment as an integrated framework to understand cancer biology. Cancer Lett. 2019. 461p. 112-122. (1).
The tumour microenvironment as an integrated framework to understand cancer biology. Burgos Panadero,R, Lucantoni,F, Gamero Sandemetrio,E, de la Cruz Merino,L, Alvaro,T, Noguera,R. CANCER LETTERS. 2019 enero 01. 461112-122. DOI:10.1016/j.canlet.2019.07.010. PMID:31325528.